The best candidates for corneal tissue addition keratoplasty fit certain topographical and visual criteria, according to a ...

At the 2026 ASCRS Annual Meeting in Washington, DC, several presentations converged on a set of questions that define the ...

Pediatric candidates were predominantly complex, with severe corneal pathology and 6/11 eyes having preexisting glaucoma, ...

Johnson & Johnson showcases new clinical data for TECNIS PureSee IOL demonstrating excellent contrast sensitivity and extended range of vision ...

Luminopia has a clinically meaningful benefit for children with severe amblyopia, according to a study presented at the ...

Success rate and eligibility criteria and recovery expectations represent essential knowledge for people who want to assess ...

The Food and Drug Administration (FDA) has approved extended dosing intervals for Eylea HD ® (aflibercept) for patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME ...

PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative ...

Successfully completed Initial Public Offering (IPO) in February 2026, raising $172.5 million and listing on Nasdaq.Reported positive topline 12-month data from Phase 1/2 trial of the Bimatoprost Drug ...

Is it a viral infection or linked to the pitch itself? OT reports on a spate of keratoconjunctivitis cases that has spread to 71 players ...

Is self-certification for AV manufacturers a safety risk? Compare FMCSA driver health requirements to the lack of independent ...

IDEAYA Biosciences (IDYA) nears key phase 3 darovasertib data in uveal melanoma, with 3–4 years cash runway and FDA potential ...